<VariationArchive VariationID="1800442" VariationName="NM_005591.4(MRE11):c.939del (p.Val313_Leu314insTer)" VariationType="Deletion" Accession="VCV001800442" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2022-12-03" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1857732" VariationID="1800442">
      <GeneList>
        <Gene Symbol="MRE11" FullName="MRE11 homolog, double strand break repair nuclease" GeneID="4361" HGNC_ID="HGNC:7230" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="94415570" stop="94512412" display_start="94415570" display_stop="94512412" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="94150465" stop="94227039" display_start="94150465" display_stop="94227039" Strand="-" />
          </Location>
          <OMIM>600814</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005591.4(MRE11):c.939del (p.Val313_Leu314insTer)</Name>
      <CanonicalSPDI>NC_000011.10:94470548:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="94470549" stop="94470549" display_start="94470549" display_stop="94470549" variantLength="1" positionVCF="94470548" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="94203715" stop="94203715" display_start="94203715" display_stop="94203715" variantLength="1" positionVCF="94203714" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.94470550del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.94470550del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.94203716del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.94203716del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007261.1" sequenceAccession="NG_007261" sequenceVersion="1" change="g.28326del">
            <Expression>NG_007261.1:g.28326del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330347.2" sequenceAccession="NM_001330347" sequenceVersion="2" change="c.939del">
            <Expression>NM_001330347.2:c.939del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317276.1" sequenceAccession="NP_001317276" sequenceVersion="1" change="p.Val313_Leu314insTer">
            <Expression>NP_001317276.1:p.Val313_Leu314insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005590.4" sequenceAccession="NM_005590" sequenceVersion="4" change="c.939del">
            <Expression>NM_005590.4:c.939del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005581.2" sequenceAccession="NP_005581" sequenceVersion="2" change="p.Val313_Leu314insTer">
            <Expression>NP_005581.2:p.Val313_Leu314insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005591.4" sequenceAccession="NM_005591" sequenceVersion="4" change="c.939del" MANESelect="true">
            <Expression>NM_005591.4:c.939del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005582.1" sequenceAccession="NP_005582" sequenceVersion="1" change="p.Val313_Leu314insTer">
            <Expression>NP_005582.1:p.Val313_Leu314insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005591.3" sequenceAccession="NM_005591" sequenceVersion="3" change="c.939delT">
            <Expression>NM_005591.3:c.939delT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_85" sequenceAccession="LRG_85">
            <Expression>LRG_85:g.28326del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_85t1" sequenceAccession="LRG_85t1">
            <Expression>LRG_85t1:c.938del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_85p1" sequenceAccession="LRG_85p1" change="p.Leu314Terfs">
            <Expression>LRG_85p1:p.Leu314Terfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005591.4(MRE11):c.939del (p.Val313_Leu314insTer) AND Hereditary cancer-predisposing syndrome" Accession="RCV002461590" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005591.4(MRE11):c.939del (p.Val313_Leu314insTer) AND Ataxia-telangiectasia-like disorder" Accession="RCV003757243" Version="1">
        <ClassifiedConditionList TraitSetID="36621">
          <ClassifiedCondition DB="MedGen" ID="C1858391">Ataxia-telangiectasia-like disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-12-03" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23080121</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23912341</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29922827</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="36621" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36734" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ataxia-telangiectasia-like disorder</ElementValue>
                <XRef ID="MONDO:0011457" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS604391" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATLD</ElementValue>
                <XRef Type="MIM" ID="604391" DB="OMIM" />
              </Symbol>
              <XRef ID="C1858391" DB="MedGen" />
              <XRef ID="MONDO:0011457" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS604391" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8327815" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="5864016|MedGen:C1858391" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004540024" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23080121</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23912341</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 1800442). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with MRE11-related conditions. This variant is present in population databases (rs765675945, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Leu314*) in the MRE11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MRE11 are known to be pathogenic (PMID: 23080121, 23912341).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MRE11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.94203715del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858391" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5391337" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-12-03">
        <ClinVarSubmissionID localKey="a546258|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002755511" DateUpdated="2024-05-01" DateCreated="2022-12-03" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29922827</ID>
          </Citation>
          <Comment>The c.939delT pathogenic mutation, located in coding exon 8 of the MRE11A gene, results from a deletion of one nucleotide at nucleotide position 939. This changes the amino acid from a leucine to a stop codon (p.L314*). This alteration has been detected in 0/3030 patients with pancreatic cancer and 1/123136 controls (Hu C et al. JAMA, 2018 06;319:2401-2409). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MRE11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005591.3:c.939delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122_ResubmissionBatch1</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8327815" TraitType="Disease" MappingType="XRef" MappingValue="C1858391" MappingRef="MedGen">
        <MedGen CUI="C1858391" Name="Ataxia-telangiectasia-like disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5391337" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

